COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1
|
|
- Anna Webb
- 5 years ago
- Views:
Transcription
1 Journal of Cell and Tissue Research Vol. 10(3) (2010) ISSN: (Available online at Original Article COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1 SUMIT KUMAR, VAISHAKHI, T. 1, PRATIK, C. 1 Biotechnology Department, VVP Engineering College, Rajkot ; 1 Bioinformatics Programme, Applied Mathematics Department, M. S. University of Vadodara, Baroda E mail: btsumit@gmail.com Received: October 1, 2010; Accepted: October 30, 2010 Abstract: The multiple sequence analysis of 300 sequences of gp160 of HIV-1 using Clustal yielded sites having amino acids showing varying degree of conservation. The positive selection of mutation in terms of polar, non-polar, hydrophilic and hydrophobic amino acids for the selected sites showed great degree of variation. The findings of this work could assist in the better understanding of selective pressure exerted on the conservation of certain amino acids at the selected regions in the gp160 protein. This in turn could contribute towards designing of potential drugs to combat the menace of HIV infection and AIDS. Key words: HIV type-1, Bioinformatics, Conservation, Mutation, gp160.? INTRODUCTION Human immunodeficiency virus (HIV) is a lent virus which cause acquired immunodeficiency syndrome (AIDS). World statistics of HIV/AIDS by UNAIDS in 2008 says roughly 33.4 million people living with HIV infections. Estimated number of people living with HIV infection in India is 2.31 million [1]. The major problem for unavailability of drugs or vaccine against HIV infection is high mutation rate of HIV [2,3]. Mutation is well observed in laboratory experiments and clinical studies but still the exact mechanism of mutation is not known. Many hypotheses are proposed to explain mutation rate in HIV. One theory is that error-prone Reverse Transcriptase (RT) is responsible for generation of variation after each cycle of replication. So when RT composes pro-viral DNA, there will be nucleotide mis-transmission due to substitution, deletion, addition etc [4,5]. Another theory explains high diversity of HIV as recombination between each unique HIV virion in infected individual during life span of infection [6,7]. Whatever the mechanism HIV likes to apply for generation of diversity but the concern for human is failure of any traditional way of disease prevention. Apart from regular mutational diversity, there exists some major kind of diversity/species in HIV called HIV-1 and HIV-2. HIV-1 is the virus that was initially discovered and termed lymphadenopathy-associated virus (LAV) [8]. HIV-1 is more virulent, more infective and is the cause of the majority of HIV infections globally while HIV-2 is limited to West Africa due to its low infectivity [9]. Based on phylogenetic relationship, HIV-1 is further divided into 3 sub types/clades called M, N and O. Type M of HIV-1 is predominant and includes further 9 subtypes: A, B, C, D, F, G, H, J and K which are genetically diverging by % in env gene and % in gag gene [10,11]. Type N is found only in Cameroon and has very low global predominance. HIV-1 variants not included in type-m or type-n are classified as type-o [12]. For the better understanding of the mechanism and nature of HIV mutation and persistence, structural and bioinformatics analysis is carried out by some research groups but still a strong conclusion about mechanism and drug failure is remained left due to complexity of study. Therefore, the present study aims to analyze the conserved and mutated amino acids in the gp160 protein of HIV-1 from the resources available on various websites. 2359
2 J. Cell Tissue Research MATERIALS AND METHODS Collection of gp160 protein sequence of HIV Type-1: The human immunodeficiency virus is known for its frequent mutation and variation, resulting in the great diversity in genome sequences as well amino acid sequences of produced proteins. The genome sequences and their translated amino acid sequences are available freely on various websites. For the present investigation, about 300 translated amino acid sequences of gp160 protein were collected from different HIV type-1 genomes including different subtypes like A1, B, and C from HIV sequence database available at mainpage.html. These retrieved genome sequences were stored using FASTA format. Multiple sequence alignment using Clustal X: The Clustal X software freely available from website was used for the multiple sequence alignment of the collected amino acid sequences of gp160 protein of HIV type-1. The alignment was facilitated by loading the FASTA file in Clustal X and by using its multiple sequence alignment function. The use of different colour tags assisted in locating the proper alignment among the similar sequences and in the finding of mismatched sequences if any. The results of these alignments were used to identify the variation in amino acids of various gp160 proteins of HIV-1. Positive selection of mutation: After multiple sequence alignment of amino acid sequences of gp160 proteins, on the basis of colour tags, variation in amino acids at the same position was identified. The regions with less than 30% similarities were selected to determine the maximum variation in amino acids among the selected sequences. The variations in amino acids at same position in different sequences were grouped into polar amino acids versus non-polar amino acids and hydrophilic versus hydrophobic amino acids, using the features of MS-Excel Determination of conserved amino acids: Among the aligned amino acid sequences of gp160 proteins, the conserved amino acids were indicated by using colour tags at the same position. The regions with 100% similarities at same position were selected from among all sequences. This analysis was done manually using the features of MS-Excel The results thus obtained were subjected to statistical analysis to draw the useful conclusions. Statistical analysis: It was performed to determine per cent mutation, per cent conservation using the features of MS-Excel The data obtained from statistical analysis were used making result tables and graphs to arrive at significant conclusions. RESULTS AND DISCUSSION Conserved amino acids in HIV-1 subtype A1: The multiple sequence alignment for the selected sites in gp160 protein of HIV-1 subtype A1 has yielded first conserved site is a region between 125 to 132 (of 8 amino acids) flanked by two different conserved sites of two amino acids having only one gap, the second conserved site between 282 to 287 (of 6 amino acids) with only one gap at 281 and a conserved region of two amino acids at as shown in figure 1(a) and (b). The conserved region between 282 and 287 is present at the exposed surface of gp120 envelope protein, as shown in figure 3. From the literatures, it was found that the great variability in HIV-1 antigenic epitopes is one of the major mechanisms used by the virus to evade the host immune response. To elicit broadly neutralizing antibody (NAb) against HIV-1, one or more conserved epitopes should be recognized to overcome the extensive antigenic diversity. The major targets of HIV-1 neutralizing antibodies are located on the surface gp120, whose diverse antigenic epitopes mediate receptor and co receptor binding, and on the transmembrane gp41, which causes membrane fusion and allows the virus to gain entry into host cells. The antigenic diversity of HIV-1 is a major tool used by the virus as an immune evasion strategy, and this poses a major obstacle for the development of an effective HIV-1 vaccine. Therefore, a major focus of vaccine developers has been the difficulty in the elicitation of a broadly neutralizing antibody response. In this work we have studied a limited number of conserved amino acid sequences, which can be treated as epitopes on the envelope glycoprotein of HIV-1 primary isolates. The data thus obtained from this study would assist in the design of synthetic peptides, with a greater potential to combat the menace of AIDS. 2360
3 Sumit Kumar et al. 2361
4 J. Cell Tissue Research A1: The selected sites in the gp160 protein of HIV- 1 subtype A1 include different amino acid positions such as 32, 137, 441 and 915. The multiple sequence alignment for these selected positions showed variation in more than 15 amino acids at a unique position. The aligned sequences of amino acids showed replacement of amino acids of same group. The variation in the same amino acid group was noticed in more than 70% cases, in terms of polar, non-polar, hydrophilic and hydrophobic amino acids, as represented in figure 4. In the present study, it is found that a few amino acid sites undergo positive selection and play a critical role in adapting the HIV-1 virus against the host immune response. It is found that at site-32, out of 87 selected sequences of HIV-1 of subtype A1, 76 showed positive selection in being the polar amino acids while 09 showed selection in being the nonpolar amino acids. Similarly, at site-441, out 87 sequences, 59 showed positive selection in being the polar and 28 being the non-polar amino acids. At site- 137, out of 87 sequences, 62 showed positive selection in being the non-polar and 24 being the polar amino acids. At site-915, out of 87 sequences, only 2 showed in being the polar while 80 being the non-polar amino acids. For these selected sites, the hydrophilic amino acids constituted 87.35%, 65.51%, 16.09% and 3.44% respectively, while the hydrophobic amino acids constituted 10.34%, 32.18%, 82.75% and 90.80% respectively. Conserved amino acids in HIV-1 subtype B: The multiple sequence alignment for the selected sites in gp160 protein of HIV-1 subtype B has yielded first conserved site is a region between 45 to 55 (of 11 amino acids) with no gap and the second site 288 to 295 (of 8 amino acids) with no any gap as represented in the figure 1 (c) and (d). It is determined that the second conserved region is present at the surface of gp120 protein of HIV-1 as shown in figure 3. B: The selected sites in the gp160 protein of HIV-1 subtype B include different amino acid positions such as 95, 146, 442, 710 and 599. The aligned sequences of amino acids showed replacement of amino acids of same group. The variation in the same amino acid group was noticed in more than 70% cases, in terms of polar, non-polar, hydrophilic and hydrophobic amino acids, as represented in figure 5. In the present study, it is found that a few amino acid sites undergo positive selection and play a critical role in adapting the HIV-1 virus against the host immune response. It is found that at site-32, out of 87 selected sequences of HIV-1 of subtype A1, 76 showed positive selection in being the polar amino acids while 09 s howed selection in being the nonpolar amino acids. Similarly, at site-441, out 87 sequences, 59 showed positive selection in being the polar and 28 being the non-polar amino acids. At site- 137, out of 87 sequences, 62 showed positive selection in being the non-polar and 24 being the polar amino acids. At site-915, out of 87 sequences, only 2 showed in being the polar while 80 being the non-polar amino acids. For these selected sites, the hydrophilic amino acids constituted 87.35%, 65.51%, 16.09% and 3.44% respectively, while the hydrophobic amino acids constituted 10.34%, 32.18%, 82.75% and 90.80% respectively. Conserved amino acids in HIV-1 subtype B: The multiple sequence alignment for the selected sites in gp160 protein of HIV-1 subtype B has yielded first conserved site is a region between 45 to 55 (of 11 amino acids) with no gap, the second conserved site is between 288 to 295 (of 8 amino acids) with no any gap as represented in the figure-1 (c) and (d). Its determined that the second conserved region is present at the surface of gp120 protein of HIV-1. This conserved site is same as that of at the surface of gp120 protein of HIV-1 subtype A1 at site 2, as shown in figure-3. B: The selected sites in the gp160 protein of HIV-1 subtype B include different amino acid positions such as 95, 146, 442, 710 and 599. The aligned sequences of amino acids showed replacement of amino acids of same group. The variation in the same amino acid group was noticed in more than 70% cases, in terms of polar, non-polar, hydrophilic and hydrophobic amino acids, as represented in figure 5. In the present study, it is found that a few amino acid sites undergo positive selection and play a critical role in adapting the HIV-1 virus against the host immune response. It is found that at site-95, out of 2362
5 Sumit Kumar et al. Fig.4: Nature of amino acids at the four selected sites in gp160 of HIV-1 subtype A Site-32 Site-441 Site-137 Site-915 Number of polar amino acids Number of non-polar amino acids Number of hydrophilic amino acids Number of hydrophobic amino acids Fig. 5: Nature of amino acids at the five selected sites in gp160 of HIV-1 subtype B Number of polar amino acids Number of non polar amino acids Number of hydrophilic amino acids Number of hydrophobic amino acids 0 Site-95 Site-146 Site-442 Site-599 Site-710 Fig 6: Nature of amino acids at the four selected sites in gp160 of HIV-1 subtype C Number of polar amino acids Number of non-polar amino acids Number of hydrophilic amino acids Number of non-polar amino acids 0 Site-372 Site-383 Site-430 Site-491 Site sequences, 70 showed positive selection in being the non-polar while 30 being the polar amino acids, at site-146, out of 100 selected sequences, 71 showed positive selection in being the polar amino acids while rest 28 showed selection in being the non-polar amino acids. Similarly, at site 442, out 100 sequences, 80 showed positive selection in being the polar and 20 being the non-polar amino acids. At site-710, out of 100 sequences, 99 showed positive selection in being the polar and only 1 being the non-polar amino acids. At site 599, out of 100 sequences, 98 showed positive selections in being the non-polar while only 2 being the polar amino acids. For these selected sites, the hydrophilic amino acids constituted 30%, 71%, 73%, 97% and 2% respectively, while the hydrophobic amino acids constituted 70%, 28%, 27%, 3% and 98% respectively. Conserved amino acids in HIV-1 subtype C: The multiple sequence alignment for the selected sites in gp160 protein of HIV-1 subtype C has yielded 2363
6 J. Cell Tissue Research first conserved site is a region between 421 to 4264 (of 6 amino acids) with no gap, the second conserved site is between 582 to 587 (of 6 amino acids) with no gap as shown in the figure-2 (a) and (b). C: The selected sites in the gp160 protein of HIV-1 subtype C include different amino acid positions such as 372, 383, 430, 491 and 699. The aligned sequences of amino acids showed replacement of amino acids of same group. The variation in the same amino acid group was noticed in major cases, in terms of polar, non-polar, hydrophilic and hydrophobic amino acids, as represented in figure 5. It is found that at site-372, out of 100 selected sequences of HIV-1 of subtype C, all 100 showed positive selection in being the polar amino acids while no single amino acid showed selection in being the non-polar amino acids. Similarly, at site-383, out of 100 sequences, 81 showed positive selection in being the polar and 19 being the non-polar amino acids. At site 430, out of 100 sequences, 79 showed positive selection in being the polar and 31 being the nonpolar amino acids. At site 491, out of 100 sequences, 93 showed positive selections in being the polar while only 7 being the non-polar amino acids. At site-699, out of 100 sequences, 87 showed positive selections in being the polar while 13 being the non-polar amino acids. For these selected sites, the hydrophilic amino acids constituted 99%, 81%, 78%, 93% and 83% respectively, while the hydrophobic amino acids constituted 1%, 19%, 32%, 7% and 17% respectively. CONCLUSION The positive selection of mutation in terms of polar, non-polar, hydrophilic and hydrophobic amino acids for the selected sites showed great degree of variation. Multiple sequence analysis of gp120 also yielded conserved amino acids throughout 300 sequences. Comparison between these conserved sites and already determined structure of gp120 showed that one of the conserved sites is available on surface of gp120 protein. Another finding of this work could assist in the better understanding of selective pressure exerted on the conservation of certain amino acids at the selected regions in the gp160 protein. This in turn could contribute towards designing of potential drugs to combat the menace of HIV infection and AIDS. FUTURE PROSPECTIVE The outcomes of this work can be exploited for developing antibodies against the most conserved regions of gp160 protein of HIV-1 as well as designing of potential drugs to combat the menace of HIV infection. The work will also help to understand the selective pressure exerted on the conservation of polar, non-polar, hydrophilic or hydrophobic amino acids of gp160 protein. ACKNOWLEDGEMENTS The authors wish to acknowledge Dr. Dhanesh Patel of Applied Mathematics Department of M. S. University of Baroda for providing the necessary infrastructure as well as technical support required for this work. REFERENCES [1] UNAIDS: AIDS epidemic update : November 2009: (2009). [2] Hutchinson, J.F.: Annual Rev. Anthropol., 30: (2001). [3] Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M.: Nature, 373: (1995). [4] Dougherty, J.P. and Temin, H.M.: J. Virol., 62(8): (1988). [5] O Neil, P.K., Sun, G., Yu, H., Ron, Y., Dougherty, J.P. and Preston, B.D.: J. Biol. Chem., 277 (41): (2002). [6] Ramirez, B.C., Simon-Loriere, E., Galetto, R. and Negroni, M.: Virus Res., 134: (2008). [7] Kijak, G.H. and McCutchan, F.E.: Current Infectious Disease Reports, 7: (2005). [8] Basavapathruni, A. and Anderson, K.S.: The FASEB J., 21: (2007). [9] Gilbert, P.B., McKeague, I.W., Eisen, G., Mullins, C., Gueye-NDiaye, A., Mboup, S. and Kanki, P.J.: Statistics Med., 22: (2003). [10] Kantor, R., Katzenstein, D.A., Efron, B., Carvalho, A.P., Wynhoven, B., Cane, P., Clarke, J., Sirivichayakul, S., Soares, M.A., Snoeck, J., Pillay, C., Rudich, H., Rodrigues, R., Holguin, A., Ariyoshi, K., Bouzas, M.B., Cahn, P., Sugiura, W., Soriano, V., Brigido, L.F. et.al.: PLoS Med., 2(4): (2005). [11] Geretti, A.M.: Current Opinion in Infectious Diseases, 19: 1-7 (2006). [12] Gurtler, L.G., Hauser, P.H., Eberle, J., Brunn, A.V., Knapp, S., Zekeng, L., Tsague, J.M. and Kaptue, L.: J. Virol., 68 (3): (1994). 2364
Immune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa
African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationA VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART
BIOE 301 LECTURE 10 MITALI BANERJEE A VACCINE FOR HIV HIV HAART Visit wikipedia.org and learn the mechanism of action of the five classes of antiretroviral drugs. (1) Reverse transcriptase inhibitors (RTIs)
More informationMultiple sequence alignment
Multiple sequence alignment Bas. Dutilh Systems Biology: Bioinformatic Data Analysis Utrecht University, February 18 th 2016 Protein alignments We have seen how to create a pairwise alignment of two sequences
More informationCD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120
CD4 T Cell Decline Is Not Associated With Amino Acid Changes in HIV-1 gp120 Colin Wikholm and Isai Lopez BIOL 368: Bioinformatics Laboratory Department of Biology Loyola Marymount University November 15,
More informationLESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV
LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent
More informationRajesh Kannangai Phone: ; Fax: ; *Corresponding author
Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal
More informationIdentification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist
Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1
More informationWeek 5 Section. Junaid Malek, M.D.
Week 5 Section Junaid Malek, M.D. HIV: Anatomy Membrane (partiallystolen from host cell) 2 Glycoproteins (proteins modified by added sugar) 2 copies of RNA Capsid HIV Genome Encodes: Structural Proteins
More informationEMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)
AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,
More informationOn an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures
HIV-1 evolution in response to immune selection pressures BISC 441 guest lecture Zabrina Brumme, Ph.D. Assistant Professor, Faculty of Health Sciences Simon Fraser University http://www3.niaid.nih.gov/topics/hivaids/understanding/biology/structure.htm
More informationLow ds/dn Does Not Correlate With High Variation of Amino Acid Sequences Along the gp120 Protein Structure
Low ds/dn Does Not Correlate With High Variation of Amino Acid Sequences Along the gp120 Protein Structure Zach Goldstein & Jordan Detamore BIOL 368: Bioinformatics Laboratory Department of Biology Loyola
More informationFor all of the following, you will have to use this website to determine the answers:
For all of the following, you will have to use this website to determine the answers: http://blast.ncbi.nlm.nih.gov/blast.cgi We are going to be using the programs under this heading: Answer the following
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More informationHIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual)
HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual) BACKGROUND Human Immunodeficiency Virus ( HIV ) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to
More informationHIV-1 acute infection: evidence for selection?
HIV-1 acute infection: evidence for selection? ROLLAND Morgane University of Washington Cohort & data S6 S5 T4 S4 T2 S2 T1 S1 S7 T3 DPS (days post symptoms) 3 (Fiebig I) 7 (Fiebig I) 13 (Fiebig V) 14 (Fiebig
More informationDETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester
DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview
More informationBiomedical Engineering for Global Health. Lecture 10 HIV/AIDS vaccine development
Biomedical Engineering for Global Health Lecture 10 HIV/AIDS vaccine development Review of lecture 9 How do vaccines work? Types ofvaccines: Review of lecture 9 Are vaccines effective? -Edward Jenner s
More informationHOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS
HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS Somda&a Sinha Indian Institute of Science, Education & Research Mohali, INDIA International Visiting Research Fellow, Peter Wall Institute
More informationExploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein
Microbes Count! 137 Video IV: Reading the Code of Life Human Immunodeficiency Virus (HIV), like other retroviruses, has a much higher mutation rate than is typically found in organisms that do not go through
More informationGoing Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution.
Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Brian T. Foley, PhD btf@lanl.gov HIV Genetic Sequences, Immunology, Drug Resistance and Vaccine Trials
More informationCDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm
More informationHIV INFECTION: An Overview
HIV INFECTION: An Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ
More informationJulianne Edwards. Retroviruses. Spring 2010
Retroviruses Spring 2010 A retrovirus can simply be referred to as an infectious particle which replicates backwards even though there are many different types of retroviruses. More specifically, a retrovirus
More informationEVOLUTION. Reading. Research in my Lab. Who am I? The Unifying Concept in Biology. Professor Carol Lee. On your Notecards please write the following:
Evolution 410 9/5/18 On your Notecards please write the following: EVOLUTION (1) Name (2) Year (3) Major (4) Courses taken in Biology (4) Career goals (5) Email address (6) Why am I taking this class?
More informationRunning Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS. An Understanding of HIV- 1, Symptoms, and Treatments.
Running Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS An Understanding of HIV- 1, Symptoms, and Treatments Benjamin Mills Abstract HIV- 1 is a virus that has had major impacts worldwide. Numerous
More informationMutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey
Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC
More informationDoes A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence
Does A Significant Change in CD4 Cell Count Affect The Number of Amino Acid Mutations In A Subject s Corresponding DNA Sequence Courtney Merriam and Shivum Desai Biology 368: Bioinformatics Loyola Marymount
More information5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1
Epidemiology 227 April 24, 2009 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 60 questions and 9 pages on the examination. Each question will count one point.
More informationARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za
ARV Mode of Action Mode of Action Mode of Action - NRTI Mode of Action - NNRTI Mode of Action - Protease Inhibitors Mode of Action - Integrase inhibitor Mode of Action - Entry Inhibitors Mode of Action
More informationInvestigation of the genetic differences between bovine herpesvirus type 1 variants and vaccine strains
Investigation of the genetic differences between bovine herpesvirus type 1 variants and vaccine strains Name: Claire Ostertag-Hill Mentor: Dr. Ling Jin Bovine herpesvirus Bovine herpesvirus-1 (BHV-1) Pathogen
More informationHIV Infection and Epidemiology: Can There Be a Cure? Dr. Nedwidek
HIV Infection and Epidemiology: Can There Be a Cure? Dr. Nedwidek The Viral Life Cycle A typical virus (DNA or RNA + protein) enters the host cell, makes more of itself, and exits. There are two major
More informationSome living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)
Section: 1.1 Question of the Day: Name: Review of Old Information: N/A New Information: We tend to only think of animals as living. However, there is a great diversity of organisms that we consider living
More informationTITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of
More informationSequence Analysis of Human Immunodeficiency Virus Type 1
Sequence Analysis of Human Immunodeficiency Virus Type 1 Stephanie Lucas 1,2 Mentor: Panayiotis V. Benos 1,3 With help from: David L. Corcoran 4 1 Bioengineering and Bioinformatics Summer Institute, Department
More information7.014 Problem Set 7 Solutions
MIT Department of Biology 7.014 Introductory Biology, Spring 2005 7.014 Problem Set 7 Solutions Question 1 Part A Antigen binding site Antigen binding site Variable region Light chain Light chain Variable
More informationCh 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems
Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Highlight Disease: Malaria World s dominant protozoal disease. Four species of Plasmodium: P. falciparum (malignant), P. vivax (begnin),
More informationLecture 11. Immunology and disease: parasite antigenic diversity
Lecture 11 Immunology and disease: parasite antigenic diversity RNAi interference video and tutorial (you are responsible for this material, so check it out.) http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html
More informationCenters for Disease Control August 9, 2004
HIV CDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm
More informationA PROJECT ON HIV INTRODUCED BY. Abdul Wahab Ali Gabeen Mahmoud Kamal Singer
A PROJECT ON HIV INTRODUCED BY Abdul Wahab Ali Gabeen Mahmoud Kamal Singer Introduction: Three groups of nations have been identified in which the epidemiology of HIV(Human Immunodeficiency Virus) varies:
More informationChapter 14 Part One Biotechnology and Industry: Microbes at Work
Chapter 14 Part One Biotechnology and Industry: Microbes at Work Objectives: After reading Chapter 14, you should understand How biotechnology has resulted in numerous pharmaceutical products to help lessen
More informationMedChem 401~ Retroviridae. Retroviridae
MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The
More informationHIV Anti-HIV Neutralizing Antibodies
,**/ The Japanese Society for AIDS Research The Journal of AIDS Research : HIV HIV Anti-HIV Neutralizing Antibodies * Junji SHIBATA and Shuzo MATSUSHITA * Division of Clinical Retrovirology and Infectious
More informationYUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan
JOURNAL OF VIROLOGY, May 2000, p. 4335 4350 Vol. 74, No. 9 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Reevaluation of Amino Acid Variability of the Human
More informationA Path to an HIV Vaccine: GSID Consortium Activities. Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009
A Path to an HIV Vaccine: GSID Consortium Activities Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009 Project Goals Acquire and disseminate information that will contribute to the
More informationChronic HIV-1 Infection Frequently Fails to Protect against Superinfection
Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Anne Piantadosi 1,2[, Bhavna Chohan 1,2[, Vrasha Chohan 3, R. Scott McClelland 3,4,5, Julie Overbaugh 1,2* 1 Division of Human
More informationHuman Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set
Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set Catalog Number : SEK11695 To achieve the best assay results, this manual must be read carefully before using this product
More informationNonsynonymous Amino Acid Mutations in gp120 Binding Sites are Related to Progression of HIV-1
Nonsynonymous Amino Acid Mutations in gp120 Binding Sites are Related to Progression of HIV-1 Matthew Allegretti and Anindita Varshneya BIOL 368: Bioinformatics Laboratory Loyola Marymount University November
More informationAn Evolutionary Story about HIV
An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst
More informationPatterns of hemagglutinin evolution and the epidemiology of influenza
2 8 US Annual Mortality Rate All causes Infectious Disease Patterns of hemagglutinin evolution and the epidemiology of influenza DIMACS Working Group on Genetics and Evolution of Pathogens, 25 Nov 3 Deaths
More informationHIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital
HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per
More informationHS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.
Unit 2, Lesson 2: Teacher s Edition 1 Unit 2: Lesson 2 Influenza and HIV Lesson Questions: o What steps are involved in viral infection and replication? o Why are some kinds of influenza virus more deadly
More informationMID-TERM EXAMINATION
Epidemiology 227 May 2, 2007 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 75 questions and 11 pages on the examination. Each question will count one point. Notify
More informationHuman Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS
Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s
More informationHigh Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure
More informationCDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm
More informationLentiviruses: HIV-1 Pathogenesis
Lentiviruses: HIV-1 Pathogenesis Human Immunodeficiency Virus, HIV, computer graphic by Russell Kightley Tsafi Pe ery, Ph.D. Departments of Medicine and Biochemistry & Molecular Biology NJMS, UMDNJ. e-mail:
More information, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic
1 Two attributes make AIDS unique among infectious diseases: it is uniformly fatal, and most of its devastating symptoms are not due to the causative agent Male to Male sex is the highest risk group in
More informationGOVX-B11: A Clade B HIV Vaccine for the Developed World
GeoVax Labs, Inc. 19 Lake Park Drive Suite 3 Atlanta, GA 3 (678) 384-72 GOVX-B11: A Clade B HIV Vaccine for the Developed World Executive summary: GOVX-B11 is a Clade B HIV vaccine targeted for use in
More informationCitation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside
UvA-DARE (Digital Academic Repository) RNAi based gene therapy for HIV-1, from bench to bedside Von Eije, K.J. Link to publication Citation for published version (APA): Von Eije, K. J. (2009). RNAi based
More informationRama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
More informationAnalysis of protein modeling for envelope glycoprotein GP120 for HIV via bioinformatics approaches
International Research Journal of Virology Vol. 1(1), pp. 002-006, March, 2014. www.premierpublishers.org ISSN: 2326-7193x IRJV Research Article Analysis of protein modeling for envelope glycoprotein GP120
More informationMolecular diagnosis of infectious bronchitis: recent developments. Richard Currie
Molecular diagnosis of infectious bronchitis: recent developments Richard Currie The infectious bronchitis virus RNA (nucleic acid) on the inside the genetic finger print Proteins (S1 and S2 spike proteins)
More informationEmerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors
Emerging Viruses Part IIb Follow Up from Part I Vaccines and Inhibitors Cellular Responses to Viral Invasion: Restriction Factors Cells fight viral infection using a series of restriction factors Restriction
More informationBioinformation Volume 5
Identification of sequence mutations affecting hemagglutinin specificity to sialic acid receptor in influenza A virus subtypes Usman Sumo Friend Tambunan*, Ramdhan Department of Chemistry, Faculty of Mathematics
More informationnumbe r Done by Corrected by Doctor
numbe r 5 Done by Mustafa Khader Corrected by Mahdi Sharawi Doctor Ashraf Khasawneh Viral Replication Mechanisms: (Protein Synthesis) 1. Monocistronic Method: All human cells practice the monocistronic
More informationVIROLOGY. Engineering Viral Genomes: Retrovirus Vectors
VIROLOGY Engineering Viral Genomes: Retrovirus Vectors Viral vectors Retrovirus replicative cycle Most mammalian retroviruses use trna PRO, trna Lys3, trna Lys1,2 The partially unfolded trna is annealed
More informationHEPATITIS B: are escape mutants of concern?
VACCINATION: AN EVOLUTIONARY ENGINE FOR SPECIES? Fondation Mérieux Conference Centre Veyrier-du-Lac, France November 25-27, 2013 HEPATITIS B: are escape mutants of concern? Alessandro ZANETTI Department
More informationExam 1-Key. Biology II Winter 2013
Exam 1-Key Biology II Winter 2013 Multiple Choice Questions. Circle the one best answer for each question. (2 points each) 1. Which of the following is part of the Cell Theory? A. All organisms are composed
More informationModeling the Antigenic Evolution of Influenza Viruses from Sequences
Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.
More informationChapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003
Chapter 13 Viruses, Viroids, and Prions Biology 1009 Microbiology Johnson-Summer 2003 Viruses Virology-study of viruses Characteristics: acellular obligate intracellular parasites no ribosomes or means
More informationUnit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS
1 Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS What steps are involved in viral infection and replication? Why are some kinds of influenza virus more deadly than others? How do flu
More informationFrom Mosquitos to Humans: Genetic evolution of Zika Virus
Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical
More informationBuilding complexity Unit 04 Population Dynamics
Building complexity Unit 04 Population Dynamics HIV and humans From a single cell to a population Single Cells Population of viruses Population of humans Single Cells How matter flows from cells through
More informationHIV & AIDS: Overview
HIV & AIDS: Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR VJ TEMPLE 1 What
More informationDEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED
DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED Viv Peut Kent Laboratory, University of Melbourne, Australia WHY ENVELOPE? Env subject to both humoral and cellular immune responses Perhaps
More informationReverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review
pissn 2349-2910 eissn 2395-0684 REVIEW Reverse transcriptase and protease inhibitor resistant mutations in art treatment naïve and treated hiv-1 infected children in India A Short Review Dinesh Bure, Department
More informationImmunodeficiency. (2 of 2)
Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related
More informationNK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections
NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections Amy Chung Dr. Ivan Stratov Prof. Stephen Kent ADCC process consists of Target cell QuickTime and a TIFF (Uncompressed) FcγR decompressor
More information3. on T helper {cells / lymphocytes} ; 3. ACCEPT macrophages / dendritic cells / CD4 cells
1(a) 1. (structure G is {glycoprotein / gp120} ; 2. used for {attachment / eq} to CD4 (molecules / receptors /antigens) ; 1. IGNORE gp 41 and gp 160 and other wrong numbers 3. on T helper {cells / lymphocytes}
More informationACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS
ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS Acquired immunodeficiency syndrome (AIDS ) is an infectious disease caused by a retrovirus, the human immunodeficiency virus(hiv). AIDS is
More informationLESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication
DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit
More informationIrina Maljkovic Berry
Thesis for doctoral degree (Ph.D.) 2008 Thesis for doctoral degree (Ph.D.) 2008 Genetic aspects of HIV-1 evolution and transmission Irina Maljkovic Berry Genetic aspects of HIV-1 evolution and transmission
More informationPalindromes drive the re-assortment in Influenza A
www.bioinformation.net Hypothesis Volume 7(3) Palindromes drive the re-assortment in Influenza A Abdullah Zubaer 1, 2 * & Simrika Thapa 1, 2 1Swapnojaatra Bioresearch Laboratory, DataSoft Systems, Dhaka-15,
More informationUnder the Radar Screen: How Bugs Trick Our Immune Defenses
Under the Radar Screen: How Bugs Trick Our Immune Defenses Session 7: Cytokines Marie-Eve Paquet and Gijsbert Grotenbreg Whitehead Institute for Biomedical Research HHV-8 Discovered in the 1980 s at the
More informationStudent Handout Bioinformatics
Student Handout Bioinformatics Introduction HIV-1 mutates very rapidly. Because of its high mutation rate, the virus will continue to change (evolve) after a person is infected. Thus, within an infected
More informationBioinformatics Laboratory Exercise
Bioinformatics Laboratory Exercise Biology is in the midst of the genomics revolution, the application of robotic technology to generate huge amounts of molecular biology data. Genomics has led to an explosion
More informationMicro 301 HIV/AIDS. Since its discovery 31 years ago 12/3/ Acquired Immunodeficiency Syndrome (AIDS) has killed >32 million people
Micro 301 HIV/AIDS Shiu-Lok Hu hus@uw.edu December 3, 2012 Since its discovery 31 years ago Acquired Immunodeficiency Syndrome (AIDS) has killed >32 million people In 2011 34.0 million [31.4 35.9 million]
More informationInfluenza Virus HA Subtype Numbering Conversion Tool and the Identification of Candidate Cross-Reactive Immune Epitopes
Influenza Virus HA Subtype Numbering Conversion Tool and the Identification of Candidate Cross-Reactive Immune Epitopes Brian J. Reardon, Ph.D. J. Craig Venter Institute breardon@jcvi.org Introduction:
More informationPatricia Fitzgerald-Bocarsly
FLU Patricia Fitzgerald-Bocarsly October 23, 2008 Orthomyxoviruses Orthomyxo virus (ortho = true or correct ) Negative-sense RNA virus (complementary to mrna) Five different genera Influenza A, B, C Thogotovirus
More informationUniversity of Cape Town
The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgement of the source. The thesis is to be used for private
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/35908 holds various files of this Leiden University dissertation Author: Soema, Peter Title: Formulation of influenza T cell peptides : in search of a universal
More informationJ. A. Sands, 21 October 2013 Lehigh University
J. A. Sands, 21 October 2013 Lehigh University Cryptococcus, Candidiasis, Aspergillosis Tuberculosis Cholera Plague Bact. Meningitis Salmonella Listeria Leptospirosis Staph. (MRSA) E. coli Clostridium
More informationMonte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies
Monte Carlo Simulation of HIV-1 Evolution in Response to Selection by Antibodies Jack da Silva North Carolina Supercomputing Center, MCNC, Research Triangle Park, NC; jdasilva@ncsc.org Austin Hughes Department
More informationIntroduction to the Impact of Resistance in Hepatitis C
Introduction to the Impact of Resistance in Hepatitis C Sponsored by AbbVie 2/1/2017 Presented by Sammy Saab, MD, MPH, FACG, AGAF, FAASLD February 1 st, 2017 1 AbbVie disclosures This is an Abbvie sponsored
More informationThe Swarm: Causes and consequences of HIV quasispecies diversity
The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008 Mutation, mutation, mutation Success of HIV largely due to its ability
More information(ii) The effective population size may be lower than expected due to variability between individuals in infectiousness.
Supplementary methods Details of timepoints Caió sequences were derived from: HIV-2 gag (n = 86) 16 sequences from 1996, 10 from 2003, 45 from 2006, 13 from 2007 and two from 2008. HIV-2 env (n = 70) 21
More informationOriginally published as:
Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681
More information7.013 Spring 2005 Problem Set 7
MI Department of Biology 7.013: Introductory Biology - Spring 2005 Instructors: Professor Hazel Sive, Professor yler Jacks, Dr. Claudette Gardel 7.013 Spring 2005 Problem Set 7 FRIDAY May 6th, 2005 Question
More information